Cargando…
Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
Osteoporosis and cardiovascular (CV) disease share common risk factors and pathophysiology. Low bone mineral density (BMD) and fractures appear to increase the risk for multiple CV diseases. Equally, prevalent CV disease appears to predispose to bone loss and increase fracture rates. This relationsh...
Autores principales: | Rodríguez, Alexander J, Abrahamsen, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260817/ https://www.ncbi.nlm.nih.gov/pubmed/34258509 http://dx.doi.org/10.1002/jbm4.10522 |
Ejemplares similares
-
Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
por: Rodríguez, Alexander J, et al.
Publicado: (2022) -
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
por: Reginster, J-Y., et al.
Publicado: (2011) -
Management of Osteoporosis in Men: A Narrative Review
por: Vescini, Fabio, et al.
Publicado: (2021) -
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs
por: Fuggle, N. R., et al.
Publicado: (2020) -
Osteoporosis in the Setting of Shoulder Arthroplasty: A Narrative Review
por: Daher, Mohammad, et al.
Publicado: (2023)